Crypto asset manager 21Shares submitted an amended registration statement (S-1/A) for an Injective (INJ) spot ETF (S-1) to the U.S. Securities and Exchange Commission (SEC) on the 18th (local time), CryptoBriefing reported. If approved, the ETF will trade on Nasdaq under the ticker 'TINJ' and will track the price of INJ based on the FTSE Injective Index. It also includes a strategy to stake a portion of the held INJ at the discretion of the asset manager to reflect staking rewards. However, this submission does not signify approval for the ETF's launch, and final approval will be determined after SEC review. According to CoinMarketCap, INJ is currently trading at $6.59, up 14.98%.
